Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Immunogenicity and Seroconversion With Sabin Inactivated Polio Vaccine Schedules in China.

NCT03597919 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention, China as lead sponsor.

NCT NCT03597919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03597919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Immunogenicity and Seroconversion With Sabin Inactivated Polio Vaccine Schedules in China.
Lead sponsor
Centers for Disease Control and Prevention, China
Phase
Phase 4
Overall status
Completed
Start date
May 28, 2018
Completion date
January 15, 2020
Enrollment
560 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

poliomyelitis